FindTrial
Sign In

Preliminary study for differential expression spectrum of serum exosomes miRNA in patients with nonalcoholic fatty liver disease

Preliminary study for differential expression spectrum of serum exosomes miRNA in patients with nonalcoholic fatty liver disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019425
Enrollment
Unknown
Registered
2018-11-10
Start date
2018-11-30
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease

Interventions

Case series:Nil

Sponsors

the Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for NAFLD patients: Non-alcoholic fatty liver disease diagnosed according to the diagnostic criteria; aged between 20 and 65 years old. Non-NAFLD control group: Healthy people.

Exclusion criteria

Exclusion criteria: NAFLD patients exclusion criteria: viral liver disease, hepatolenticular degeneration, autoimmune liver disease, drug-induced liver disease and other causes of fatty liver or liver dysfunction, excluding long-term drinking history and alcohol intake equivalent to ethanol: male > 140g/Week, female > 70g/week. Non-NAFLD exclusion criteria: Any of hypertension, hyperlipidemia, diabetes, liver disease,kidney disease, or major systemic diseases.

Design outcomes

Primary

MeasureTime frame
height;weigh;Waist circumference;Hip circumference;blood pressure;—

Countries

China

Contacts

Public ContactYingdi Liu

the Chinese PLA General Hospital

liuyingdi301@sina.com+86 13901351481

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026